Biological E seeks DCGI emergency use nod for Corbevax as booster in adults vaccinated with Covaxin, Covishield Ruchika Sharma12 May 2022 1:40 PM ISTAccording to the EUA application submitted to DCGI, Biological E in a phase-3 placebo-controlled clinical study, based on the drug regulator's nod,...
Bharat Biotech, CEPI collaborate to develop 'variant-proof' COVID vaccine Ruchika Sharma11 May 2022 12:24 PM ISTCEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1...
COVID vaccine makers shift focus to booster shots Ruchika Sharma10 May 2022 11:00 AM ISTPfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...
COVID drug makers posting record profits, but treatment out of reach for poor, says WHO MD Bureau8 May 2022 10:00 AM ISTCalling it a "moral failing" Ghebreyesus said that "we cannot accept prices that make life-saving treatments available to the rich and out of reach...
AstraZeneca booster effective against severe COVID: UK study Ruchika Sharma7 May 2022 10:00 AM ISTThe research supports the use of the AstraZeneca booster for protection against severe disease with COVID-19 in settings that have not yet offered...
Recombinant plant-based Covid-19 vaccine promising for infection control: NEJM Medical Dialogues Editorial Team6 May 2022 10:06 AM ISTCanada: In a new study conducted by Karen J. Hager and team, it was shown that the Coronavirus-like particles (CoVLP) + Adjuvant System 03 (AS03)...
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine Susmita Roy5 May 2022 7:10 PM ISTNew Delhi: Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis...
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
SC finds no haste in granting EUA to covishield, covaxin MD Bureau3 May 2022 1:08 PM ISTThe bench said: "The material provided by the Union of India, comprising minutes of the meetings of the SEC, do not warrant the conclusion that...
Antibiotics use in children below 2 years tied to reduced vaccine response: Study Medha Baranwal3 May 2022 10:00 AM ISTNew York: Antibiotic use in children aged 6 to 24 months is associated with reduced vaccine-induced antibody levels to several vaccines, states a...
USFDA VRBPA committee to review Novavax COVID vaccine Ruchika Sharma2 May 2022 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2.
